Introduction The role of platelets (Ps) and platelet-derived microparticles (MPs) in venous
thromboembolism (VTE) is still being debated. Methods We measured MPs, velocity of …

Abstract Background Microvesicles (MVs) are small double‐membrane encapsulated
particles shed from cells. Case‐control studies have reported elevated plasma levels of …

Microparticles (MPs) are blebs released from cellular surfaces during activation/apoptosis.
They are procoagulant, pro-inflammatory and could contribute to pathogenesis of deep …

Platelet-derived microparticles (PDMP) are first ob-served as vesicles released from
platelets after adhesion to vessels walls. 1–3 Circulating PDMP can therefore be thought of …

BACKGROUND: Flow cytometry has shown levels of platelet-derived microparticles (PMPs)
and endothelial-derived microparticles (EMPs) to be elevated in deep-vein thrombosis …

Platelet-derived microvesicles (PMV) that are released from activated platelets have a high
procoagulant potential, and this is believed to be the result of surface exposure of functional …

Blood contains microparticles (MPs) derived from a variety of cell types, including platelets,
monocytes, and endothelial cells. In addition, tumors release MPs into the circulation. MPs …

BACKGROUND: Cancer is a prothrombotic state, with an increased prevalence of venous
thromboembolism (VTE). Microparticles (MPs) are sub-micron-sized vesicles derived from …

The extent of the involvement of platelets in venous thromboembolisms (VTE) is still not fully
understood. Immature platelets are large, RNA-rich, prothrombotic platelets. They are …

Microparticles (MP) are lipid vesicles from platelets, leukocytes and endothelial cells that are
involved in early thrombogenesis. We evaluated a detailed time-course analysis of MPs on …